IMGO
Imago BioSciences Inc

72
Loading...
Loading...
Imago BioSciences, Inc. operates as a clinical-stage biopharmaceutical company that develops novel anti-cancer therapeutics. It translates science of genetics and epigenetics enzymes into novel medicines for treating myeloid diseases that pose challenges to patients, families, and physicians. The company also translates insights into transformative therapies that alter the history of disease allowing patients to live longer and disease-free lives. Imago BioSciences was founded by Hugh Young Rienhoff, Jr., Laura G. Eichorn and Jennifer Peppe on March 29, 2012 and is headquartered in Redwood City, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Imago BioSciences Inc?
What is the 52-week high for Imago BioSciences Inc?
What is the 52-week low for Imago BioSciences Inc?
What was Imago BioSciences Inc stock price yesterday?
What is the PE ratio of Imago BioSciences Inc?
What is the Price-to-Book ratio of Imago BioSciences Inc?
What is the 50-day moving average of Imago BioSciences Inc?

Latest IMGO News

View
No IMGO news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.